IĸBζ is a central modulator of inflammatory arthritis pathogenesis.
Gaurav SwarnkarMusarrat NaazDorothy MimsPrashant GuptaTimothy PetersonMatthew J ChristopherSrikanth SingamaneniGabriel MbalavieleYousef Abu-AmerPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Our study positions IĸBζ as an inflammation-specific target for therapeutic consideration in RA as its inhibition spares the beneficial functions of NF-ĸB.